Daily BriefsEvent-Driven

Daily Brief Event-Driven: Merger Arb Mondays (18 Jul) – Link Admin and more

In today’s briefing:

  • Merger Arb Mondays (18 Jul) – Link Admin, AOF, DTAC/True, Ramsay Health, ResApp, Infomedia
  • ANZ to Acquire Suncorp Bank: Equity Raise & Regulatory Approvals
  • Weekly Deals Digest (17 Jul): WCP, BYD, Link, Genting Singapore, DTAC/True, AOF, ResApp
  • S&P/ASX200: West African Resources (WAF) Replaces Uniti (UWL) At 21 July Close
  • GSK Spinoff Haleon (HLN UK) Is Biggest New Euro Listing In 10yrs – Index Implications and Overhang


ANZ to Acquire Suncorp Bank: Equity Raise & Regulatory Approvals

By Brian Freitas

  • Australia and New Zealand Banking Group (ANZ) (ANZ AU) has announced that it is acquiring Suncorp Bank from Suncorp (SUN AU) for an all cash consideration of A$4.9bn.
  • ANZ will fund the Suncorp Bank acquisition by a fully underwritten 1:15 pro rata accelerated renounceable entitlement offer to raise A$3.5bn at A$18.9/share, a 12% discount to TERP.
  • A small increase in the Herfindahl-Hirschman Index (HHI) for the mortgage lending market will make it difficult for ACCC to deny approval for the acquisition.

Weekly Deals Digest (17 Jul): WCP, BYD, Link, Genting Singapore, DTAC/True, AOF, ResApp

By Arun George


S&P/ASX200: West African Resources (WAF) Replaces Uniti (UWL) At 21 July Close

By Travis Lundy

  • The Uniti Group Ltd (UWL AU) Scheme Meeting was held Friday, approving both General Scheme Resolution and Rollover Shares Scheme unanimously. The MBD Bidco deal is done. 
  • Friday after the close, the S&P DJI Global Index team announced that Uniti would be deleted from the ASX200 21 July at the close.
  • Gold miner West African Resources (WAF AU) was chosen as the replacement. It’s a decent-sized inclusion and should have been well-flagged last week but may have been ignored.

GSK Spinoff Haleon (HLN UK) Is Biggest New Euro Listing In 10yrs – Index Implications and Overhang

By Travis Lundy

  • GlaxoSmithKline PLC (GSK LN) shareholders on 6 July overwhelmingly approved the long-awaited demerger of its GSK Consumer Healthcare unit newly-named Haleon (HLN LN) earlier this month. 
  • While not originally universally-desired (Elliott wanted a sale), it was overwhelmingly approved. Haleon lists Monday 18 July with a £40+bn valuation resulting in FTSE 100 and Stoxx Europe 600 changes.
  • GSK investors get 1 share of Haleon for every share of GSK held. Post-demerger, the public owns 55%, Pfizer ~32%, GSK ~13%. Lockup ends 10 November. There will be overhang.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars